Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.

about

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.

Item

http://www.wikidata.org/entity/Q55003884

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@en

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@nl

type

Item

label

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@en

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@nl

prefLabel

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@en

Strategies to Genetically Modu ...... s in Hematologic Malignancies.

@nl

P1476

Strategies to Genetically Modu ...... es in Hematologic Malignancies

@en

P2093

Annelisa M Cornel

http://www.w3.org/2001/XMLSchema#string

Jaap Jan Boelens

http://www.w3.org/2001/XMLSchema#string

Niek P van Til

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells

Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?

Dendritic cells and the control of immunity

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

Cancer immunotherapy via dendritic cells

The regulation of IL-10 production by immune cells

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.

Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia

P304

982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00982

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Nierkens

P577

2018-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867960

http://www.w3.org/2001/XMLSchema#string

P921

hematologic cancer

hemic and immune systems

Achyolli

P932

5968097

http://www.w3.org/2001/XMLSchema#string